Loading...
Loading...
Supernus Pharmaceuticals
SUPN moved up 26.51% to $8.40 in the pre-market session after the company received final approval from the FDA for Trokendi XR.
Partner Communications Company
PTNR soared 3.75% to $8.02 in the pre-market trading. Partner Communications is expected to report its reviewed financial results for the second quarter on August 28, 2013.
Chesapeake Energy
CHK surged 3% to $25.75 in the pre-market session after Carl Icahn lifted his stake in Chesapeake to 9.98% from 8.98%.
MannKind
MNKD shares gained 2.77% to $5.93 in the pre-market session. MannKind's PEG ratio is 0.06.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in